Dogwood Therapeutics Inc. (DWTX)
NASDAQ: DWTX
· Real-Time Price · USD
4.82
-0.08 (-1.63%)
At close: Sep 18, 2025, 3:59 PM
4.96
2.90%
After-hours: Sep 18, 2025, 07:35 PM EDT
Dogwood Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -3.81M | -10.92M | -7.73M | -2.28M | -1.05M | -1.29M | -1.1M | -1.24M | -1.44M | -1.52M | -2.04M | -2.58M | -3.67M | -3.96M | -4.51M | -4.11M | -4.28M | -3.06M |
Depreciation & Amortization | 17.26K | 17.02K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | 93.8K | 94.3K | 148.95K | 138.97K | 148.31K | 148.31K | 161.66K | 161.7K | 149.53K | 164.27K | 136.96K | 131.91K | 131.91K | 131.91K | 34.24K | 24.82K |
Other Working Capital | 310.81K | -111.54K | -2.04M | 968.82K | 138.36K | 130.11K | -420.85K | 135.25K | 457.62K | 94.79K | -703.81K | -51.99K | -461.68K | 1.2M | -669.12K | 1.11M | 1.85M | -2.61M |
Other Non-Cash Items | 59.85K | 6.28M | 3.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Deferred Income Tax | 149.00 | 190.54K | -503 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -296.02K | -243.02K | -2.16M | 1.28M | 89.14K | 214.95K | -514.3K | 126.31K | 536.83K | -343.28K | -776.38K | -71.79K | -126.83K | 1.17M | -798.75K | 1.33M | 1.5M | -2.08M |
Operating Cash Flow | -4.03M | -4.68M | -6.13M | -910.14K | -811.75K | -937.41K | -1.47M | -960.45K | -742.41K | -1.7M | -2.67M | -2.48M | -3.66M | -2.66M | -5.18M | -2.65M | -2.75M | -5.11M |
Capital Expenditures | n/a | 4.00 | n/a | -3 | -4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | 3.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | 3.76M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 3M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3M | n/a | 15.32M | n/a | n/a | n/a | -1.16M | n/a | n/a | n/a | n/a | 4.58M | n/a | n/a | n/a | n/a | n/a | -97.6K |
Financial Cash Flow | -120.13K | 7.37M | 15.32M | -70.23K | 1.45M | n/a | n/a | 1.16M | n/a | n/a | -86K | 4.58M | n/a | n/a | n/a | n/a | n/a | -97.6K |
Net Cash Flow | -4.14M | 2.69M | 12.81M | -980.36K | 640.65K | -937.41K | -1.47M | 195.99K | -742.41K | -1.7M | -2.76M | 2.09M | -3.66M | -2.66M | -5.18M | -2.65M | -2.75M | -5.21M |
Free Cash Flow | -4.03M | -4.68M | -6.13M | -910.14K | -811.75K | -937.41K | -1.47M | -960.45K | -742.41K | -1.7M | -2.67M | -2.48M | -3.66M | -2.66M | -5.18M | -2.65M | -2.75M | -5.11M |